GB1567515A - Esters of testo-sterone and 5 -dihydro-testosterone - Google Patents
Esters of testo-sterone and 5 -dihydro-testosterone Download PDFInfo
- Publication number
- GB1567515A GB1567515A GB2131477A GB2131477A GB1567515A GB 1567515 A GB1567515 A GB 1567515A GB 2131477 A GB2131477 A GB 2131477A GB 2131477 A GB2131477 A GB 2131477A GB 1567515 A GB1567515 A GB 1567515A
- Authority
- GB
- United Kingdom
- Prior art keywords
- testosterone
- alkyl
- esters
- weight
- cyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0025—Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/691,103 US4098802A (en) | 1975-02-18 | 1976-05-28 | Oral pharmaceutical preparation having androgenic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1567515A true GB1567515A (en) | 1980-05-14 |
Family
ID=24775172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2131477A Expired GB1567515A (en) | 1976-05-28 | 1977-05-20 | Esters of testo-sterone and 5 -dihydro-testosterone |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS52148060A (fi) |
| AR (1) | AR214323A1 (fi) |
| BE (1) | BE855163A (fi) |
| CH (1) | CH627761A5 (fi) |
| DE (1) | DE2723876C2 (fi) |
| DK (1) | DK146096C (fi) |
| ES (1) | ES459230A1 (fi) |
| FI (1) | FI57597C (fi) |
| FR (1) | FR2352832A1 (fi) |
| GB (1) | GB1567515A (fi) |
| NL (1) | NL7705790A (fi) |
| SE (1) | SE425493B (fi) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002015938A2 (en) * | 2000-08-23 | 2002-02-28 | Akzo Nobel N.V. | Testosterone ester formulation for human use |
| US7718640B2 (en) | 2003-03-14 | 2010-05-18 | Bayer-Schering Pharma Ag | Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| US9012436B2 (en) | 2008-04-28 | 2015-04-21 | Diurnal Limited | Lipid composition |
| US11311555B2 (en) | 2010-11-30 | 2022-04-26 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
| TW201521731A (zh) * | 2013-03-15 | 2015-06-16 | 利波辛股份有限公司 | 用於口服之脂平衡的長鏈睪固酮酯 |
| US20180147215A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189235C (nl) * | 1974-02-28 | 1993-02-16 | Akzo Nv | Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking. |
-
1977
- 1977-05-20 GB GB2131477A patent/GB1567515A/en not_active Expired
- 1977-05-24 CH CH640477A patent/CH627761A5/de not_active IP Right Cessation
- 1977-05-25 JP JP6170477A patent/JPS52148060A/ja active Granted
- 1977-05-26 FI FI771684A patent/FI57597C/fi not_active IP Right Cessation
- 1977-05-26 FR FR7716182A patent/FR2352832A1/fr active Granted
- 1977-05-26 DE DE19772723876 patent/DE2723876C2/de not_active Expired
- 1977-05-26 NL NL7705790A patent/NL7705790A/xx not_active Application Discontinuation
- 1977-05-27 ES ES459230A patent/ES459230A1/es not_active Expired
- 1977-05-27 BE BE178016A patent/BE855163A/xx not_active IP Right Cessation
- 1977-05-27 SE SE7706235A patent/SE425493B/xx not_active IP Right Cessation
- 1977-05-27 AR AR26780777A patent/AR214323A1/es active
- 1977-05-27 DK DK236877A patent/DK146096C/da not_active IP Right Cessation
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002015938A2 (en) * | 2000-08-23 | 2002-02-28 | Akzo Nobel N.V. | Testosterone ester formulation for human use |
| WO2002015938A3 (en) * | 2000-08-23 | 2002-08-15 | Akzo Nobel Nv | Testosterone ester formulation for human use |
| JP2004506698A (ja) * | 2000-08-23 | 2004-03-04 | アクゾ・ノベル・エヌ・ベー | ヒトに用いるためのテストステロンエステル製剤 |
| AU2001291775B2 (en) * | 2000-08-23 | 2005-09-08 | N.V. Organon | Testosterone ester formulation for human use |
| US7718640B2 (en) | 2003-03-14 | 2010-05-18 | Bayer-Schering Pharma Ag | Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| US8338395B2 (en) | 2003-03-14 | 2012-12-25 | Bayer Intellectual Property Gmbh | Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| US9012436B2 (en) | 2008-04-28 | 2015-04-21 | Diurnal Limited | Lipid composition |
| US11311555B2 (en) | 2010-11-30 | 2022-04-26 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11364249B2 (en) | 2010-11-30 | 2022-06-21 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11364250B2 (en) | 2010-11-30 | 2022-06-21 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2352832B1 (fi) | 1980-07-11 |
| ES459230A1 (es) | 1978-11-16 |
| FI57597C (fi) | 1980-09-10 |
| DE2723876A1 (de) | 1977-12-15 |
| SE7706235L (sv) | 1977-11-29 |
| JPS52148060A (en) | 1977-12-08 |
| FI57597B (fi) | 1980-05-30 |
| DK236877A (da) | 1977-11-29 |
| DK146096B (da) | 1983-06-27 |
| AR214323A1 (es) | 1979-05-31 |
| JPS6145637B2 (fi) | 1986-10-08 |
| CH627761A5 (en) | 1982-01-29 |
| FI771684A (fi) | 1977-11-29 |
| FR2352832A1 (fr) | 1977-12-23 |
| DK146096C (da) | 1983-11-21 |
| DE2723876C2 (de) | 1986-10-30 |
| BE855163A (fr) | 1977-11-28 |
| NL7705790A (nl) | 1977-11-30 |
| SE425493B (sv) | 1982-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4083973A (en) | Pharmaceutical preparation adapted for oral administration | |
| US4071623A (en) | Pharmaceutical preparation adapted for oral administration | |
| US4147783A (en) | Oral pharmaceutical preparation | |
| US4220599A (en) | Oral pharmaceutical preparation having androgenic activity | |
| US4098802A (en) | Oral pharmaceutical preparation having androgenic activity | |
| US5149695A (en) | Fumaric acid derivatives, process for the production thereof and pharmaceutical compositions containing same | |
| JPS6296422A (ja) | 子宮内膜増殖症予防または治療用組成物の製造方法およびその来成物を用いる前記増殖症の予防または治療方法 | |
| GB1567515A (en) | Esters of testo-sterone and 5 -dihydro-testosterone | |
| RU94046044A (ru) | Новые 7 бета -замещенные 4-аза- 5 альфа -холестан-оны в качестве ингибиторов 5 альфа -редуктазы, фармацевтическая композиция на их основе, способ ее получения | |
| IL37026A (en) | Pharmaceutical preparations containing vitamin a derivatives | |
| GB1565229A (en) | K-estrane compounds and pharmaceutical compositions containing same | |
| US3450821A (en) | Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof | |
| US4431833A (en) | Prostaglandin and hydroxylated fatty acid ester formulations | |
| CA1113926A (en) | Pharmaceutical preparation adapted for oral administration | |
| CA2110336A1 (en) | Nonatetraenoic acid derivative | |
| CA1098034A (en) | Pharmaceutical preparation adapted for oral administration | |
| ES486049A1 (es) | Procedimiento para la obtencion de derivados aminopropanoli-cos de la 6-hidroxi-2,3,4,5-tetrahidro-1h-1-benzazepin-2-ona | |
| US3764620A (en) | Novel azalkane prostaglandin compounds | |
| CA1083139A (en) | Pharmaceutical preparation adapted for oral administration | |
| Okonkwo et al. | Fatty livers induction by orotic acid contained in skim milk powder | |
| US3644628A (en) | Compositions having testosterone antagonistic effects and method of using the same | |
| HU193238B (en) | Process for preparing indanyl-derivatives and pharmaceutical compositions containing such compounds | |
| KR820000180B1 (ko) | 폴리엔 화합물의 제조방법 | |
| FR2566407A1 (fr) | Nouveaux derives de l'isoxazoloquinoleine, procede de preparation, application a titre de medicaments, et compositions les renfermant | |
| US3509157A (en) | 23,24-secostrychnidine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |